Compare NFE & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NFE | SOPH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 330.4M |
| IPO Year | 2019 | 2021 |
| Metric | NFE | SOPH |
|---|---|---|
| Price | $1.22 | $4.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $7.70 | $7.00 |
| AVG Volume (30 Days) | ★ 9.3M | 56.8K |
| Earning Date | 02-27-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,768,624,000.00 | $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | $27.93 | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $0.98 | $2.58 |
| 52 Week High | $16.66 | $5.30 |
| Indicator | NFE | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 59.24 |
| Support Level | $1.04 | $4.52 |
| Resistance Level | $1.30 | $4.82 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 58.33 | 87.27 |
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.